Barclays’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9K Sell
11,666
-87,197
-88% -$179K ﹤0.01% 4588
2025
Q4
$278K Buy
98,863
+11,624
+13% +$27K ﹤0.01% 4159
2025
Q3
$180K Sell
87,239
-20,297
-19% -$56.1K ﹤0.01% 4375
2025
Q2
$339K Buy
107,536
+45,779
+74% +$140K ﹤0.01% 3976
2025
Q1
$194K Sell
61,757
-839
-1% -$3.32K ﹤0.01% 4063
2024
Q4
$272K Buy
62,596
+9,507
+18% +$29.7K ﹤0.01% 4161
2024
Q3
$142K Buy
53,089
+39,542
+292% +$93.4K ﹤0.01% 4469
2024
Q2
$30.1K Buy
+13,547
New +$51.1K ﹤0.01% 4361
2022
Q3
Sell
-4
Closed 4836
2022
Q2
$0 Sell
4
-6,184
-100% -$10.4K ﹤0.01% 5061
2022
Q1
$16K Buy
+6,188
New +$21.9K ﹤0.01% 4499
2020
Q2
Sell
-348
Closed 5657
2020
Q1
$0 Sell
348
-17,709
-98% -$25K ﹤0.01% 6178
2019
Q4
$22K Buy
18,057
+17,709
+5,089% +$25.2K ﹤0.01% 5960
2019
Q3
$1K Hold
348
﹤0.01% 6581
2019
Q2
$1K Hold
348
﹤0.01% 6826
2019
Q1
$1K Buy
348
+1
+0.3% +$4 ﹤0.01% 6900
2018
Q4
$1K Hold
347
﹤0.01% 6784
2018
Q3
$2K Hold
347
﹤0.01% 6930
2018
Q2
$2K Hold
347
﹤0.01% 6815
2018
Q1
$9K Hold
347
﹤0.01% 6676
2017
Q4
$8K Hold
347
﹤0.01% 6560
2017
Q3
$18K Sell
347
-357
-51% -$22.3K ﹤0.01% 5837
2017
Q2
$64K Buy
704
+185
+36% +$11.9K ﹤0.01% 5198
2017
Q1
$44K Buy
519
+127
+32% +$17.2K ﹤0.01% 5406
2016
Q4
$60K Buy
392
+387
+7,740% +$90.4K ﹤0.01% 5048
2016
Q3
$2K Buy
+5
New +$1.82K ﹤0.01% 6217
2016
Q2
Hold
0
6356
2015
Q4
Sell
-2
Closed -$1K 6057
2015
Q3
$1K Sell
2
-5
-71% -$2.62K ﹤0.01% 6513
2015
Q2
$5K Buy
+7
New +$4.96K ﹤0.01% 6436
2014
Q3
Sell
-19
Closed -$4K 7669
2014
Q2
$4K Buy
+19
New +$6.08K ﹤0.01% 7178

Other funds holding CRDF